Few point mutations in elongation factor-1γ gene in gastrointestinal carcinoma

Molecular Carcinogenesis

Volumn 22, Issue 1, 1998, Pages 9-15

  Frazier, Marsha L ^a   Inamdar, Nikhil ^a   Alvula, Silpa ^a   Wu, Elsie ^a   Kim, Yeul Hong ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Colorectal carcinoma; Elongation factor 1 ; Pancreatic adenocarcinoma

Indexed keywords

ELONGATION FACTOR 1; ELONGATION FACTOR 1GAMMA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOT HYBRIDIZATION; GASTROINTESTINAL CARCINOMA; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; NORTHERN BLOTTING; NUCLEIC ACID BASE SUBSTITUTION; PANCREAS CANCER; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOUTHERN BLOTTING;

3T3 CELLS; ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; CELL CYCLE; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; GASTRIC MUCOSA; GASTROINTESTINAL NEOPLASMS; HUMANS; MICE; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PEPTIDE ELONGATION FACTOR 1; PEPTIDE ELONGATION FACTORS; POINT MUTATION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031833627     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199805)22:1<9::AID-MC2>3.0.CO;2-J     Document Type: Article

References (28)

1. Chi K, Jones DV, Frazier ML. Expression of an elongation factor-1 gamma related sequence in adenocarcinomas of the colon. Gastroenterology 103:98-102, 1992.
2. Ender B, Lynch P, Frazier ML. Overexpression of an elongation factor-1 γ-hybridizing RNA in colorectal adenomas. Mol Carcinog 6:1-3, 1993.
3. Lew Y, Jones DV, Mars WM, Evans D, Byrd D, Frazier ML. Expression of elongation factor-1 gamma related sequence in human pancreatic cancer. Pancreas 7:144-152, 1992.
4. Mimori K, Mori M, Tanaka S, Akiyoshi T, Sugimachi K. The overexpression of elongation factor-1 gamma mRNA in gastric carcinoma. Cancer 75(Suppl):1446-1449, 1995.
5. Mimori K, Mori M, Inoue H, et al. Elongation factor-1γ mRNA expression in esophageal carcinoma. Gut 38:66-70, 1996.
6. Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345:544-547, 1990.
7. Benedetti AD, Rhoads RE. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci USA 87:8212-8216, 1990.
8. Tatsuka M, Mitsui H, Wada M, Nagata A, Nojima H, Okayama H. Elongation factor-1α gene determines susceptibility to transformation. Nature 359:333-336, 1992.
9. Frazier ML, Mars WM, Florine D, Montagna R, Saunders G. Efficient extraction of RNA from mammalian tissue. Mol Cell Biochem 56:113-122, 1983.
10. Gross-Bellard M, Oudet P, Chambon P. Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem 36:32-38, 1973.
11. Feinburg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments of specific activity. Anal Biochem 132:6-13, 1983.
12. Clark SJ, Krieg PA, Wells JRE. Isolation of a clone containing human histone genes. Nucleic Acids Res 9:1583-1590, 1986.
13. Cleveland DW, Lopata MA, MacDonald RJ, Cowan NJ, Rutter WJ, Kirschner MW. Number and evolutionary conservation of α-and β-tubulin and cytoplasmic β-and γ-actin genes using specific cloned cDNA probes. Cell 320:95-105, 1980.
14. Kafatos FC, Jones WC, Efstratiadis A. Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure. Nucleic Acids Res 7:1541-1552, 1979.
15. Raboudi SH, Mitchell BD, Stern MP, et al. Type II diabetes mellitus and polymorphism of insulin-receptor gene in Mexican Americans. Diabetes 38:975-980, 1989.
16. Willson JKV, Bittner GN, Oberly TD, Meisner LF, Weese JL. Cell culture of human colon adenomas and carcinomas. Cancer Res 47:2704-2713, 1987.
17. Kraft R, Tardiff J, Krauter KS, Leinwand LA. Using mini-prep plasmid DNA for sequencing double stranded templates with sequenase. Biotechniques 6:455-457, 1988.
18. Janssen GMC, Moller W. Elongation factor 1 beta gamma from Artemia. Eur J Biochem 171:119-129, 1988.
19. Slobin L, Moller W. Purification and properties of an elongation factor functionally analogous to bacterial elongation factors Ts from embryos of Artemia salina. Eur J Biochem 84:69-77, 1978.
20. Belle R, Derancourt J, Poulhe R, Capony JP, Ozon R, Mulner-Lorillon O. A purified complex from Xenopus oocytes contains a p47 protein, an in vivo substrate of MPF, and a p30 protein respectively homologous to elongation factors EF-1 gamma and EF-1 beta. FEBS Lett 255:101-104, 1989.
21. r 53,000 tumor antigen messenger RNA in normal and neoplastic cells. Cancer Res 46:5738-5742, 1986.
22. Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261-263, 1979.
23. Linzer DIH, Levine AJ. Characterization of a 54 K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17:43-52, 1979.
24. Calabretta B, Kaczmarke L, Ming PM, Au F, Ming S. Expression of c-myc and other cell cycle-dependent genes in human colon neoplasia. Cancer Res 45:6000-6004, 1985.
25. Tal M, Wetzler M, Josefberg Z, et al. Sporadic amplification of the HER-2/neu protooncogene in adenocarcinoma of various tissues. Cancer Res 48:1517-1520, 1988.
26. Brodeur GM, Seeger RC, Schwab RC, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124, 1984.
27. Heisterkamp N, Stephenson JR, Groffen J, et al. Localization of the c-ab/ oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306:239-242, 1983.
28. Groffen J, Stephenson JR, Heisterkam N, de Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93-99, 1984.